LAWRENCE, Mass., Nov. 7, 2013 /PRNewswire/ -- NxStage Medical, Inc. NXTM, a leading manufacturer of innovative dialysis products, today reported third quarter financial results with total revenue within its guidance range.
Revenue for the third quarter of 2013 increased 9% to a record $66.9 million, compared with revenue of $61.2 million for the third quarter of 2012. The higher revenues were driven by increased adoption of the NxStage® System One™.
Help employers find you! Check out all the jobs and post your resume.
